title: Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds.
abstract: The balance between matrix deposition and tissue turnover is fundamental in wound healing. It is likely that the balance between proteolytic enzymes and their inhibitors contributes to this balance. Matrix metalloproteinases are clearly important in tissue turnover, but their roles in wound healing are poorly understood. To investigate this, fluid from healing wounds resulting from mastectomies was collected from 1 h to 10 d post-surgery, and was analyzed for tissue inhibitor of metalloproteinases-1 concentrations. In all cases, tissue inhibitor of metalloproteinases-1 levels were initially comparable to those in serum, but increased rapidly to significantly higher levels within two days, with a tenfold average increase for five patients. On the other hand, zymography revealed that gelatinase A (72 kDa) levels increased moderately, whereas gelatinase B levels (92 kDa) decreased an average of twofold within 4 d. In contrast, fluid from chronic wounds had significantly more gelatinolytic activity, including lower-molecular-weight proteinase species that may represent activated or superactivated gelatinase fragments, as suggested by immunoprecipitation with specific antibodies. Tissue inhibitor of metalloproteinases-1 levels were lower in chronic than in healing wounds. These data may indicate that excess proteolysis in chronic wounds retards successful healing, and results from an imbalance of proteinase and inhibitors, as well as the presence of higher levels of activated metalloproteinases.
authors: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
authors: E C
authors: EC
authors: Bullen
authors: M T
authors: MT
authors: Longaker
authors: D L
authors: DL
authors: Updike
authors: R
authors: R
authors: Benton
authors: D
authors: D
authors: Ladin
authors: Z
authors: Z
authors: Hou
authors: E W
authors: EW
authors: Howard
mesh_terms: D002908:Chronic Disease; D004789:Enzyme Activation; D005122:Exudates and Transudates / Q000737:chemistry; D018093:Gelatinases / Q000378:metabolism*; D006023:Glycoproteins / Q000032:analysis*; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D014945:Wound Healing / Q000502:physiology; D014947:Wounds and Injuries / Q000378:metabolism*
chemical_list: D006023:Glycoproteins; D061965:Matrix Metalloproteinase Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D018093:Gelatinases